ATE191006T1 - Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren - Google Patents

Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren

Info

Publication number
ATE191006T1
ATE191006T1 AT93201797T AT93201797T ATE191006T1 AT E191006 T1 ATE191006 T1 AT E191006T1 AT 93201797 T AT93201797 T AT 93201797T AT 93201797 T AT93201797 T AT 93201797T AT E191006 T1 ATE191006 T1 AT E191006T1
Authority
AT
Austria
Prior art keywords
rhesus
produce
cell lines
human monoclonal
monoclonal antibodies
Prior art date
Application number
AT93201797T
Other languages
English (en)
Inventor
Roland Beliard
Ulf Bethke
Dominique Bourel
Ahmed Bouzidi
Herve Broly
Peter Byrne
Magali Holuigue
Michael Kloft
Detlef Rohm
Original Assignee
Aetsrn
Biotest Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9207893A external-priority patent/FR2692786B1/fr
Priority claimed from DE19924224357 external-priority patent/DE4224357C2/de
Application filed by Aetsrn, Biotest Pharma Gmbh filed Critical Aetsrn
Application granted granted Critical
Publication of ATE191006T1 publication Critical patent/ATE191006T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93201797T 1992-06-26 1993-06-22 Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren ATE191006T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9207893A FR2692786B1 (fr) 1992-06-26 1992-06-26 Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant.
DE19924224357 DE4224357C2 (de) 1992-07-23 1992-07-23 Arzneimittel zur Prophylaxe von HDN, enthaltend menschliche monoclonale anti-Rhesus (D)-Antikörper

Publications (1)

Publication Number Publication Date
ATE191006T1 true ATE191006T1 (de) 2000-04-15

Family

ID=25916870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93201797T ATE191006T1 (de) 1992-06-26 1993-06-22 Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren

Country Status (12)

Country Link
US (1) US5851524A (de)
EP (1) EP0576093B1 (de)
AT (1) ATE191006T1 (de)
AU (1) AU678364B2 (de)
BR (1) BR9305557A (de)
CA (1) CA2116246A1 (de)
DE (1) DE69328135D1 (de)
FI (1) FI940811L (de)
HU (1) HUT68624A (de)
MX (1) MX9303839A (de)
PL (1) PL302438A1 (de)
WO (1) WO1994000561A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
FR2858235B1 (fr) 2003-07-31 2006-02-17 Lab Francais Du Fractionnement Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
FR2861078B1 (fr) * 2003-10-16 2007-09-21 Lab Francais Du Fractionnement NOUVELLES IgG3 UTILES POUR STIMULER LA PHAGOCYTOSE
MX2007000644A (es) 2004-07-20 2007-03-28 Symphogen As Anticuerpo policlonal recombinante anti-rhesus d y metodos de fabricacion.
PL1787126T3 (pl) 2004-07-20 2010-03-31 Symphogen As Sposób charakteryzowania poliklonalnej linii komórkowej
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
MX2009012786A (es) 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
CA2639003A1 (en) * 2008-08-20 2010-02-20 Canadian Blood Services Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations
EP2379108B1 (de) 2008-12-22 2014-06-25 F. Hoffmann-La Roche AG Immunoglobulin-reinigung
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
US20110059079A1 (en) * 2009-09-04 2011-03-10 Xoma Technology Ltd. Antibody Coformulations
CN106267405B (zh) * 2016-07-01 2019-02-19 翁炳焕 母胎血型不合溶血病治疗仪

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8906129D0 (en) * 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations

Also Published As

Publication number Publication date
PL302438A1 (en) 1994-07-25
HUT68624A (en) 1995-07-28
DE69328135D1 (de) 2000-04-27
EP0576093B1 (de) 2000-03-22
FI940811A7 (fi) 1994-02-21
FI940811A0 (fi) 1994-02-21
AU4419793A (en) 1994-01-24
BR9305557A (pt) 1997-03-25
AU678364B2 (en) 1997-05-29
WO1994000561A1 (en) 1994-01-06
FI940811L (fi) 1994-02-21
US5851524A (en) 1998-12-22
EP0576093A1 (de) 1993-12-29
MX9303839A (es) 1994-08-31
HU9400862D0 (en) 1994-06-28
CA2116246A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
NL300433I1 (en) Methods and compositions for the treatment of glomerulonephritis
MX9707021A (es) Receptor de il-7.
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
DE69328135D1 (de) Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren
EP1135477A4 (de) Humanisierte monoklonale antikörper
DE122004000036I1 (de) Therapeutische Verwendung von chimerischen und markierten Antik¦rper gegen menschlichen B Lymphozyt beschr{nkter Differenzierung antigen f}r die Behandlung von B-Zell-Lymphoma.
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IN2012DN00313A (de)
DE69233029D1 (de) Menschliche mesenchym-stammzellen aus dem mark und monoklonale antikörper spezifisch gegen diese zellen
MX9805253A (es) Antagonistas del receptor de vitronectina.
TW285667B (de)
CY1112447T1 (el) Ανθρωπινα αντισωματα για την ιντερλευκινη (ιντεrleukin) 15 (il-15)
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
DE69007799D1 (de) Pharmazeutische antigen-antikörper-komplexe enthaltende zusammensetzungen und deren anwendungen.
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
EP0493446A4 (en) Treatment of autoimmune disease
BG102667A (en) Diosgenine-containing composition
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
DE59309133D1 (de) Granulozytenbindende Antikörperkonstrukte, ihre Herstellung und Verwendung
HUP9700364A2 (hu) Fluidágyas reaktor hulladék hőkezelésére
CA2070182A1 (en) Chimeric immunoglobulin for cd4 receptors
ATE254659T1 (de) Mikroorganismen, ihre herstellung und verwendung
SE9904236D0 (sv) Immunoassay
IT1254705B (it) Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties